Stockhouse.com uses cookies on this site. By continuing to use our service, you agree to our use of cookies. Cookies are used to offer you a better browsing experience and to analyze our traffic. We also use them to share usage information with our partners. See full details.
I Agree
×
Join today and have your say! It’s FREE!

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Please Try Again
{{ error }}
By providing my email, I consent to receiving investment related electronic messages from Stockhouse.

or

Privacy Policy | Disclaimer

Sign In

Please Try Again
{{ error }}
Password Hint : {{passwordHint}}
Forgot Password?

or

Privacy Policy | Disclaimer
Please Try Again {{ error }}

Send my password

Return to Login
SUCCESS
An email was sent with password retrieval instructions. Please go to the link in the email message to retrieve your password.

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Quote  |  Bullboard  |  News  |  Opinion  |  Profile  |  Peers  |  Filings  |  Financials  |  Options  |  Price History  |  Ratios  |  Ownership  |  Insiders  |  Valuation

Theralase Technologies Inc. V.TLT

Alternate Symbol(s):  TLTFF

Healthcare Medical Devices
Theralase Technologies Inc. is a Canada-based clinical-stage pharmaceutical company. The Company is engaged in the research and development of light activated compounds and their associated drug formulations. The Company operates through two divisions: Anti-Cancer Therapy (ACT) and Cool Laser Therapy (CLT). The Anti-Cancer Therapy division develops patented, and patent pending drugs, called Photo Dynamic Compounds (PDCs) and activates them with patent pending laser technology to destroy specifically targeted cancers, bacteria and viruses. The CLT division is responsible for the Company’s medical laser business. The Cool Laser Therapy division designs, develops, manufactures and markets super-pulsed laser technology indicated for the healing of chronic knee pain. The technology has been used off-label for healing numerous nerve, muscle and joint conditions. The Company develops products both internally and using the assistance of specialist external resources.


TSXV:TLT - Post by User

Theralase Technologies Inc. > Quarterly Newsletter Release
<< Previous
 Bullboard Posts
Next >>
User Avatar Image
(186)
•••
Comment by robertshawon Feb 25, 2022 10:32am
632 Views
Post# 34461342

RE:RE:Quarterly Newsletter Release

RE:RE:Quarterly Newsletter Release
BuenaSuertaAtod wrote: Monday or Tuesday before the open souinds like a good guess as to when the 4Q21 newsletter gets released.

Anyone got a good guess as to what will be in it wro 180 day trial results?

Eoganacht wrote:
4Q20 was released on Feb 01, 2021
1Q21 was released on Apr 27, 2021
2Q21 was released on Aug 30, 2021
3Q21 was released on Nov 29, 2021

The last two quarterly newsletters were released exactly 2 months after the quarter ended.

If Theralase continues this pattern, then the 4Q21 newsletter will be released tomorrow or on Monday.

It`s not likely important news will be released on a Friday so I`m guessing Monday morning or Tuesday before the market opens.

A couple of other posters here have made the same guess. This could be a big one!




7 patients 360 days cancer free +7 patients 270 days cancer free +at least 7 patients 180 days cancer free... Royal flush...
<< Previous
 Bullboard Posts
Next >>
Dealroom for high-potential pre-IPO opportunities